HnRNP A1 and A/B interaction with PABPN1 in oculopharyngeal muscular dystrophy
about
sameAs
The evolutionarily conserved RNA binding protein SMOOTH is essential for maintaining normal muscle functionA Drosophila model of oculopharyngeal muscular dystrophy reveals intrinsic toxicity of PABPN1.PABPN1 suppresses TDP-43 toxicity in ALS disease models.RNA-binding proteins in neurodegenerative disease: TDP-43 and beyond.Nuclear poly(A)-binding protein aggregates misplace a pre-mRNA outside of SC35 speckle causing its abnormal splicing.Muscle developmental defects in heterogeneous nuclear Ribonucleoprotein A1 knockout mice.PABPN1 gene therapy for oculopharyngeal muscular dystrophyPABPN1: molecular function and muscle disease.Cytoplasmic targeting of mutant poly(A)-binding protein nuclear 1 suppresses protein aggregation and toxicity in oculopharyngeal muscular dystrophy.Expression of polyalanine stretches induces mitochondrial dysfunction.Nuclear poly(A) binding protein 1 (PABPN1) and Matrin3 interact in muscle cells and regulate RNA processing.Novel mouse models of oculopharyngeal muscular dystrophy (OPMD) reveal early onset mitochondrial defects and suggest loss of PABPN1 may contribute to pathology.A defect in the RNA-processing protein HNRPDL causes limb-girdle muscular dystrophy 1G (LGMD1G).Valproic acid is protective in cellular and worm models of oculopharyngeal muscular dystrophyPost-transcriptional regulation of Pabpn1 by the RNA binding protein HuR
P2860
Q33551387-53607C5E-CEC9-4097-91BE-CAE36E3576F6Q34518248-A8DA2793-67F8-4423-9DEC-D9F4D1A0D2BBQ35999267-2416D6A4-7485-4A27-AC89-3BE127BC2C60Q37155206-7E19D1DC-9D27-4EE3-B22F-7901B83C645EQ37507541-BD3EA53D-79FB-4818-A41A-08195CD893CCQ37637134-6DECA8EC-BF48-4DD1-8E62-391D7E914A81Q37737844-3818C07A-12F6-4462-B87D-172B482AF1BDQ38100286-A09C4F54-2A48-40F0-A9A0-413BC9A13981Q46651409-5A62103B-44C3-4C37-A22E-FE28F506568FQ46794935-86184B78-757A-4B7A-928D-6FE0DB41AD66Q47700020-DBB1D760-FABA-4AB8-9234-CAB30E0F56B6Q50962265-8A21A169-2BFC-4D22-B126-614AD0F15AFCQ53061543-2E91B5B5-B924-4F31-8D4D-637A2DF65FECQ57040047-B8CC068E-3856-40CD-8D72-1B3AF4932600Q57160226-CCB1F924-C0EC-4DF1-A064-9B63B252AE7C
P2860
HnRNP A1 and A/B interaction with PABPN1 in oculopharyngeal muscular dystrophy
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
HnRNP A1 and A/B interaction with PABPN1 in oculopharyngeal muscular dystrophy
@ast
HnRNP A1 and A/B interaction with PABPN1 in oculopharyngeal muscular dystrophy
@en
HnRNP A1 and A/B interaction with PABPN1 in oculopharyngeal muscular dystrophy
@nl
type
label
HnRNP A1 and A/B interaction with PABPN1 in oculopharyngeal muscular dystrophy
@ast
HnRNP A1 and A/B interaction with PABPN1 in oculopharyngeal muscular dystrophy
@en
HnRNP A1 and A/B interaction with PABPN1 in oculopharyngeal muscular dystrophy
@nl
prefLabel
HnRNP A1 and A/B interaction with PABPN1 in oculopharyngeal muscular dystrophy
@ast
HnRNP A1 and A/B interaction with PABPN1 in oculopharyngeal muscular dystrophy
@en
HnRNP A1 and A/B interaction with PABPN1 in oculopharyngeal muscular dystrophy
@nl
P2093
P2860
P3181
P1476
HnRNP A1 and A/B interaction with PABPN1 in oculopharyngeal muscular dystrophy
@en
P2093
Christiane Messaed
George Karpati
Janet Laganiere
Patrick Dion
Xueping Fan
P2860
P304
P3181
P356
10.1017/S0317167100002675
P407
P577
2003-08-01T00:00:00Z